Innovating Works

Aptuit

Desconocido
PRINT-AID: Multidisciplinary European training network for development of personalized anti infective medical d... APTUIT VERONA SRL participó en un H2020: H2020-MSCA-ITN-2016 According to ECDC, over 4 million healthcare-associated infections in the EU cause 37,000 deaths and cost EUR 7 billion/year. Half of them a...
2016-08-09 - 2020-12-31 | Financiado
FOLSMART: Folate Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis APTUIT VERONA SRL participó en un H2020: H2020-NMP-2014-2015 FOLSMART will bring to phase I clinical trials novel folate-based nanodevices (FBN) for the treatment of rheumatoid arthritis (RA). These na...
2015-11-25 - 2020-12-31 | Financiado
INTEGRATE: Interdisciplinary Training Network for Validation of Gram Negative Antibacterial Targets APTUIT VERONA SRL participó en un H2020: H2020-MSCA-ITN-2014 Antimicrobial resistance is posing a continuously-rising threat to global health. Indeed, one key recommendation from the recent Action plan...
2014-12-10 - 2018-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.